is semaglutide in short supply FDA says that the GLP-1 shortage over The weight loss drug shortage

Ryan Tedford (Professor of Medicine and Chief of Heart Failure and Medical Directory of Cardiac Transplantation at the Medical University of South Carolina in Charleston, SC) to discuss the nuances of managing pulmonary hypertension in the setting of left-sided heart disease

Legal agreements can be lightweight and built around clear performance milestones

Research is underway to examine how GLP-1 therapy affects muscle quality and physical function in younger populations, which should provide insights into appropriate imaging, functional testing, and lifestyle recommendations

When We Go Deeper Advanced Testing for Metabolic Health Weight loss that lasts starts with understanding what's actually happening inside your body

Without adequate replenishment, your body may struggle to function optimally

9 In a 72-week study of tirzepatide specifically for weight loss in nondiabetic patients who were overweight or obese, findings were especially dramatic ( Figure 2A and Figure 2B )